C. Kelleher

510 total citations
20 papers, 324 citations indexed

About

C. Kelleher is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, C. Kelleher has authored 20 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Urology, 5 papers in Rheumatology and 3 papers in Epidemiology. Recurrent topics in C. Kelleher's work include Urinary Bladder and Prostate Research (9 papers), Pelvic floor disorders treatments (5 papers) and Urinary Tract Infections Management (3 papers). C. Kelleher is often cited by papers focused on Urinary Bladder and Prostate Research (9 papers), Pelvic floor disorders treatments (5 papers) and Urinary Tract Infections Management (3 papers). C. Kelleher collaborates with scholars based in United Kingdom, Sweden and Australia. C. Kelleher's co-authors include Christopher R. Chapple, Zoë Kopp, Paula Nicolson, L. Cardozo, Ian Milsom, Michael Kirby, Adrian Wagg, Heinz Koelbl, Mark E. Vierhout and Stefano Salvatore and has published in prestigious journals such as BJOG An International Journal of Obstetrics & Gynaecology, Value in Health and British Journal of Health Psychology.

In The Last Decade

C. Kelleher

18 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Kelleher United Kingdom 7 294 246 140 100 20 20 324
Caty Ebel‐Bitoun France 6 188 0.6× 186 0.8× 119 0.8× 24 0.2× 9 0.5× 11 276
H. De Paepe Belgium 8 322 1.1× 364 1.5× 111 0.8× 74 0.7× 4 0.2× 9 449
Vasudha Vats United States 9 511 1.7× 539 2.2× 279 2.0× 102 1.0× 6 0.3× 9 629
Fátima Faní­ Fitz Brazil 11 261 0.9× 91 0.4× 81 0.6× 172 1.7× 3 0.1× 30 292
Hee Chang Jung South Korea 10 289 1.0× 170 0.7× 86 0.6× 211 2.1× 3 0.1× 36 352
Maria Luíza Veiga Brazil 11 266 0.9× 310 1.3× 76 0.5× 66 0.7× 5 0.3× 28 383
Kerstin Eliasson Sweden 5 293 1.0× 135 0.5× 69 0.5× 139 1.4× 4 0.2× 5 336
Regula Doggweiler United States 5 241 0.8× 232 0.9× 71 0.5× 59 0.6× 3 0.1× 11 310
Rainer Lange Germany 8 302 1.0× 195 0.8× 126 0.9× 178 1.8× 2 0.1× 14 339
W. K. Frewen United Kingdom 8 271 0.9× 219 0.9× 93 0.7× 65 0.7× 2 0.1× 8 342

Countries citing papers authored by C. Kelleher

Since Specialization
Citations

This map shows the geographic impact of C. Kelleher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Kelleher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Kelleher more than expected).

Fields of papers citing papers by C. Kelleher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Kelleher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Kelleher. The network helps show where C. Kelleher may publish in the future.

Co-authorship network of co-authors of C. Kelleher

This figure shows the co-authorship network connecting the top 25 collaborators of C. Kelleher. A scholar is included among the top collaborators of C. Kelleher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Kelleher. C. Kelleher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abrams, Paul G., C. Kelleher, David Staskin, et al.. (2014). 574 Cardiovascular safety of combination treatment with mirabegron and solifenacin in patients with overactive bladder in a randomised, double-blind, dose-ranging, Phase II study (Symphony). European Urology Supplements. 13(1). e574–e574a. 5 indexed citations
2.
Cortes, Eduardo, et al.. (2012). A comparison study of two lower urinary tract symptoms screening tools in clinical practice: The B-SAQ and OAB-V8 questionnaires. Journal of Obstetrics and Gynaecology. 32(7). 666–671. 18 indexed citations
3.
Boer, T.A. de, Stefano Salvatore, L. Cardozo, et al.. (2009). Pelvic organ prolapse and overactive bladder. Neurourology and Urodynamics. 29(1). 30–39. 135 indexed citations
4.
Brubaker, Linda, et al.. (2009). 64 CLINICAL VALIDITY OF A QUESTION TO MEASURE OVERALL SATISFACTION WITH TREATMENT FOR OVERACTIVE BLADDER SYMPTOMS. European Urology Supplements. 8(4). 136–136. 2 indexed citations
5.
6.
Nicolson, Paula, Zoë Kopp, Christopher R. Chapple, & C. Kelleher. (2007). It's just the worry about not being able to control it! A qualitative study of living with overactive bladder. British Journal of Health Psychology. 13(2). 343–359. 87 indexed citations
7.
Kelleher, C., et al.. (2007). A prospective observational study of the safety and acceptability of vaginal hysterectomy performed in a 24‐hour day case surgery setting. BJOG An International Journal of Obstetrics & Gynaecology. 114(9). 1177–1177.
8.
Kelleher, C., et al.. (2007). 719 ATTITUDES TO PRESCRIBED MEDICINES, AND THEIR INFLUENCE ON TREATMENT COMPLIANCE IN OAB. European Urology Supplements. 6(2). 202–202. 1 indexed citations
9.
Reilly, K, Ian Milsom, Steinar Hunskaar, et al.. (2006). PREVALENCE OF INCONTINENCE AND OVERACTIVE BLADDER: EUROPEAN RESULTS FROM THE EPIC STUDY. European Urology Supplements. 5(2). 116–116. 5 indexed citations
10.
Milsom, Ian, K Reilly, Steinar Hunskaar, et al.. (2006). PREVALENCE OF OVERACTIVE BLADDER SYNDROME: EUROPEAN RESULTS FROM THE EPIC STUDY. European Urology Supplements. 5(2). 115–115. 7 indexed citations
11.
Irwin, Debra E., Ian Milsom, K Reilly, et al.. (2006). PREVALENCE OF LOWER URINARY TRACT SYMPTOMS (LUTS) IN MEN: EUROPEAN RESULTS FROM THE EPIC STUDY. European Urology Supplements. 5(2). 157–157. 4 indexed citations
12.
Kelleher, C., Ian Milsom, & P. Van Kerrebroeck. (2005). 556How effective is antimuscarinic therapy in patients who have mixed urinary incontinence?. European Urology Supplements. 4(3). 141–141. 3 indexed citations
13.
Wagg, Adrian, K-E. Andersson, L. Cardozo, et al.. (2005). Nocturia: morbidity and management in adults. International Journal of Clinical Practice. 59(8). 938–945. 10 indexed citations
14.
Reeves, Penny, Zoë Kopp, Ansgar Resch, et al.. (2005). PUK7 DELIVERING TREATMENT EFFECTIVENESS: COSTS AND PERSISTENCE OF TOLTERODINE IN THE MANAGEMENT OF OAB IN FIVE EUROPEAN COUNTRIES. Value in Health. 8(6). A79–A79. 1 indexed citations
15.
Kelleher, C., et al.. (2005). 228The emotional burden of overactive bladder (OAB) symptoms on sufferers. European Urology Supplements. 4(3). 59–59. 2 indexed citations
16.
Jumadilova, Zhanna, et al.. (2005). 557Confirming the validity of patient global impression's as outcome measures in overactive bladder. European Urology Supplements. 4(3). 142–142. 1 indexed citations
18.
Kelleher, C. & Peter Braude. (1999). Recent advances: Gynaecology. BMJ. 319(7211). 689–692. 6 indexed citations
19.
Khullar, Vikram, et al.. (1998). Impact of surgery for stress incontinence on morbidity. BMJ. 317(7151). 143–143. 2 indexed citations
20.
Kelleher, C., Jacqueline Filshie, G.W. BURTON, Vikram Khullar, & L. Cardozo. (1994). Acupuncture and the Treatment of Irritative Bladder Symptoms. Acupuncture in Medicine. 12(1). 9–12. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026